Life sciences venture capital funding overcomes record lows
Companies in the life sciences sector, which includes the biotechnology and medical device industries, captured the largest share of overall venture capital during 2009, reflecting the relative strength of the sector during the economic downturn, according to PricewaterhouseCoopers. Under Recovery, a new PwC report that includes data from the PwC/NVCA
